Cargando…

Clinical Outcome of Systemic Treatment for Advanced Soft Tissue Sarcoma: Real-Life Perspective in Japan

INTRODUCTION: The median survival time of patients with advanced soft tissue sarcoma (STS) is typically <12 months. Since 2012, physicians were able to administer second- and/or third-line treatment easily in Japan, following the approval of new drugs, namely, pazopanib, eribulin, and trabectedin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakamura, Tomoki, Asanuma, Kunihiro, Hagi, Tomohito, Sudo, Akihiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567542/ https://www.ncbi.nlm.nih.gov/pubmed/33116409 http://dx.doi.org/10.2147/DDDT.S275526

Ejemplares similares

Is Lymphocyte C-Reactive Protein Ratio Useful for Predicting Survival in Patients with Non-Metastatic Soft Tissue Sarcoma?
por: Nakamura, Tomoki, et al.
Publicado: (2022)

Modified Glasgow Prognostic Score is Better for Predicting Oncological Outcome in Patients with Soft Tissue Sarcoma, Compared to High-Sensitivity Modified Glasgow Prognostic Score
por: Nakamura, Tomoki, et al.
Publicado: (2022)

The diagnostic and prognostic value of interleukin-6 in patients with soft tissue sarcomas
por: Hagi, Tomohito, et al.
Publicado: (2017)

Expression of Interleukin-6 and the Interleukin-6 Receptor Predicts the Clinical Outcomes of Patients with Soft Tissue Sarcomas
por: Nakamura, Koichi, et al.
Publicado: (2020)

Do coagulation or fibrinolysis reflect the disease condition in patients with soft tissue sarcoma?
por: Asanuma, Kunihiro, et al.
Publicado: (2022)

Infiltrative tumor growth patterns on magnetic resonance imaging associated with systemic inflammation and oncological outcome in patients with high-grade soft-tissue sarcoma
por: Nakamura, Tomoki, et al.
Publicado: (2017)

Combination of Everolimus and Bortezomib Inhibits the Growth and Metastasis of Bone and Soft Tissue Sarcomas via JNK/p38/ERK MAPK and AKT Pathways
por: Nakamura, Koichi, et al.
Publicado: (2023)

Prognostic Significance of Thrombomodulin mRNA in High‐Grade Soft Tissue Sarcomas after 10 years
por: Asanuma, Kunihiro, et al.
Publicado: (2020)

The role of soluble CD80 in patients with soft tissue tumors
por: Matsuyama, Yumi, et al.
Publicado: (2022)

Soluble programmed death-ligand 1 rather than PD-L1 on tumor cells effectively predicts metastasis and prognosis in soft tissue sarcomas
por: Asanuma, Kunihiro, et al.
Publicado: (2020)

Macrophages and vimentin in tissues adjacent to megaprostheses and mesh in reconstructive surgeries
por: Asanuma, Kunihiro, et al.
Publicado: (2022)

Significance of coagulation and fibrinolysis markers for benign and malignant soft tissue tumors
por: Asanuma, Kunihiro, et al.
Publicado: (2021)

GPR64, Screened from Ewing Sarcoma Cells, Is a Potential Target for Antibody-Based Therapy for Various Sarcomas
por: Nakamura, Koichi, et al.
Publicado: (2022)

The adverse effect of an unplanned surgical excision of foot soft tissue sarcoma
por: Nishimura, Akinobu, et al.
Publicado: (2011)

Anti-tumour effect of tocilizumab for osteosarcoma cell lines
por: Hagi, Tomohito, et al.
Publicado: (2020)

Thin Cartilage Cap May Be Related to the Spontaneous Regression in Pediatric Patients with Osteochondroma
por: Adachi, Ryohei, et al.
Publicado: (2022)

The Role of Trabectedin in Soft Tissue Sarcoma
por: Nakamura, Tomoki, et al.
Publicado: (2022)

Analysis of pulmonary nodules in patients with high-grade soft tissue sarcomas
por: Nakamura, Tomoki, et al.
Publicado: (2017)

Radiodynamic therapy with acridine orange local administration as a new treatment option for primary and secondary bone tumours
por: Matsuyama, Yumi, et al.
Publicado: (2022)

Gastric metastasis in patients with leiomyosarcoma: A case report
por: Uchiyama, Teruya, et al.
Publicado: (2023)

The value of trabectedin in the treatment of soft tissue sarcoma
por: Nakamura, Tomoki, et al.
Publicado: (2016)

Impact of tumor volume doubling time on post-metastatic survival in bone or soft-tissue sarcoma patients treated with metastasectomy and/or radiofrequency ablation of the lung
por: Nakamura, Tomoki, et al.
Publicado: (2017)

Successful treatment with cryoablation in a patient with bone metastasis in the mid-shaft femur: a case report
por: Kita, Kouji, et al.
Publicado: (2019)

Cytoskeletal Actin Structure in Osteosarcoma Cells Determines Metastatic Phenotype via Regulating Cell Stiffness, Migration, and Transmigration
por: Kita, Kouji, et al.
Publicado: (2021)

A Novel Approach to Reducing Lung Metastasis in Osteosarcoma: Increasing Cell Stiffness with Carbenoxolone
por: Kita, Kouji, et al.
Publicado: (2023)

Full-thickness chest wall resection for malignant chest wall tumors and postoperative problems
por: Asanuma, Kunihiro, et al.
Publicado: (2023)

Minimally invasive surgery using intraoperative electron-beam radiotherapy for the treatment of soft tissue sarcoma of the extremities with tendon involvement
por: Matsumine, Akihiko, et al.
Publicado: (2016)

Spontaneous pneumothorax in a 17-year-old male patient with multiple exostoses: A case report and review of the literature
por: Nakamura, Koichi, et al.
Publicado: (2021)

The Feasibility of Using the Direct Anterior Approach for Total Hip Arthroplasty or Bipolar Hemiarthroplasty to Treat Femoral Neck Fractures among the Elderly
por: Ishiguro, Shigeo, et al.
Publicado: (2022)

New screw technique for posterior column and ischial fixation from the anterior approach for acetabular fractures
por: Asanuma, Kunihiro, et al.
Publicado: (2023)

Clinical Outcome in Soft Tissue Sarcoma Patients with Lung Metastasis Who Received Metastasectomy and/or Radiofrequency Ablation: Tokai Musculoskeletal Oncology Consortium Study
por: Nakamura, Tomoki, et al.
Publicado: (2021)

The clinical outcomes of total femur prosthesis in patients with musculoskeletal tumors
por: Kakimoto, Takuya, et al.
Publicado: (2019)

Treatment of the benign bone tumors including femoral neck lesion using compression hip screw and synthetic bone graft
por: Nakamura, Tomoki, et al.
Publicado: (2015)

Effect of Neoadjuvant Therapies on Soft Tissue Sarcomas with Tail-like Lesions: A Multicenter Retrospective Study
por: Aiba, Hisaki, et al.
Publicado: (2021)

Real-World Outcome and Prognostic Factors of Pazopanib in Advanced Soft Tissue Sarcoma
por: Alshamsan, Bader, et al.
Publicado: (2021)

Real-world experience with pembrolizumab in patients with advanced soft tissue sarcoma
por: Liu, Jiayong, et al.
Publicado: (2021)

Prognostic significance of CD155 mRNA expression in soft tissue sarcomas
por: ATSUMI, SATORU, et al.
Publicado: (2013)

The clinical outcome of pazopanib treatment in Japanese patients with relapsed soft tissue sarcoma: A Japanese Musculoskeletal Oncology Group (JMOG) study
por: Nakamura, Tomoki, et al.
Publicado: (2016)

Pazopanib in advanced soft tissue sarcomas
por: Lee, Alex T. J., et al.
Publicado: (2019)

Soluble Neural-cadherin as a novel biomarker for malignant bone and soft tissue tumors
por: Niimi, Rui, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_1u5hd0oaiu51f0jt859u037p4f